Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Rev. argent. dermatol ; Rev. argent. dermatol;105: 3-3, ene. 2024.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1559271

ABSTRACT

Resumen El tumor maligno de la vaina nerviosa periférica (TMVNP) es un sarcoma de alto grado de malignidad. Es poco frecuente, agresivo y generalmente se localiza en tronco y miembros inferiores. Se presenta mayormente en pacientes con neurofibormatosis tipo 1, aunque no siempre se encuentra esta asociación. Este tumorcomparte características histológicas e inmunohistoquímicas con el melanoma, lo que puede dificultar el diagnóstico. Presentamos el caso de un paciente con TMVNP, en el cual los hallazgos histológicos iniciales condujeron a un diagnósticoerróneode melanoma.


Abstract Malignant peripheral nerve sheath tumor (MPNST) is a high-grade sarcoma. It is rare, aggressive and generally located on the trunk and lower limbs. It occurs in a high percentage of patients with neurofibormatosis type 1, although this association is not always found. This tumor shares histological and immunohistochemical characteristics with melanoma, which can make diagnosis difficult. We present the case of a patient with MPNST, in whom the initial histological findings led to an erroneous diagnosis of melanoma.

2.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1569796

ABSTRACT

Introducción: El consentimiento informado es un acto importante de la relación médico-paciente, constituye un proceso y un documento médico-legal-bioético trascendente de esta relación. En este sentido, el consentimiento se utiliza como una herramienta que favorece el diálogo y la comprensión durante el tratamiento quirúrgico. Objetivo: Brindar un análisis y actualización del tema desde el contexto de la cirugía oncológica por la importancia de esta temática en la actualidad. Métodos: Se realizó una revisión de la literatura relevante publicada sobre el tema en bases de datos PubMed, SciELO, Google Académico. Se priorizaron los últimos 5 años y los textos escritos en idiomas inglés y español. Se hizo énfasis en las palabras consentimiento, bioética y oncología. Se revisó un total de 35 artículos. Desarrollo: La creciente demanda de terapias novedosas en la medicina, y aún más en la oncología, ha planteado nuevos dilemas éticos para la sociedad. La toma de decisiones en cuestiones de salud es un elemento central de la autonomía. Existen diversos conceptos de entorno al paciente quirúrgico que padece de cáncer. Conclusiones: Aplicar la bioética a la práctica de la oncología permite acceder al escenario donde las decisiones pasan por un análisis ético. Cuando los principios bioéticos son ejercidos como un procedimiento habitual como es el consentimiento informado, la relación médico-paciente refleja acciones dirigidas a favorecer la comunicación, el respeto a la dignidad y el proceso al final de la vida.


Introduction: Informed consent is an important act of the doctor-patient relationship, it is a process and a medical-legal-bioethical document that is transcendent of this relationship. In this sense, consent is used as a tool that favors dialogue and understanding during surgical treatment. Objective: Provide an analysis and update of the topic from the context of oncological surgery due to the importance of this topic today. Methods: A review of the relevant literature published on the subject was carried out in PubMed, SciELO, Google Scholar databases, emphasizing the last 5-years, and in the English and Spanish languages, emphasizing the words consent, bioethics, and oncology. A total of 35 articles were reviewed. Development: The growing demand for novel therapies in medicine and even more in oncology, has raised new ethical dilemmas for society. Decision-making in health matters is a central element of autonomy, there are various concepts related to the surgical patient suffering from cancer. Hence the importance of consent and motivation of this work. Conclusions: Applying bioethics to the practice of oncology allows access to the scenario where decisions go through an ethical analysis. When bioethical principles are exercised as a regular procedure such as informed consent, the doctor-patient relationship reflects actions aimed at promoting communication, respect for dignity and the process at the end of life.

3.
Rev. cir. (Impr.) ; 75(4)ago. 2023.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1515242

ABSTRACT

Objetivo: El carcinoma sebáceo (CS) es una neoplasia infrecuente, de la cual no existen reportes nacionales, ni guías de manejo en Chile. El Instituto Nacional del Cáncer (INC) es un centro de referencia nacional en el manejo de patologías oncológicas; el objetivo de este trabajo es describir la experiencia y tratamiento del carcinoma sebáceo en nuestro centro. Material y Método: Se realizó una revisión retrospectiva, descriptiva, de fichas clínicas entre marzo de 2016 y marzo de 2022 en el INC, en las cuales la biopsia definitiva fuese confirmatoria de CS. Resultados: Se reclutaron 10 pacientes, 6 hombres (60%) y 4 mujeres. Edad promedio fue de 62,9 años ± 18,7 DS. En el 80% de los casos el tumor se encontró en cabeza y cuello y solo 2 casos fueron CS ocular (20%). 4 pacientes tenían asociación al Síndrome de Muir-Torre (SMT) (40%), en el 100% de la muestra se realizó tratamiento quirúrgico con resección oncológica y control de márgenes intraoperatorio, utilizándose en solo 3 casos la técnica Cirugía Micrográfica de Mohs (MMS). En 4 pacientes (40%) se realizó biopsia de linfonodo centinela (BLNC), de los cuales ninguno resulto positivo para metástasis. Ningún paciente presento recidiva local, después de la cirugía y no hubo casos de mortalidad a causa de CS. Ningún paciente recibió radioterapia, quimioterapia o inmunoterapia adyuvante, solo 1 paciente recibió braquiterapia (BT) adyuvante. Conclusión: El CS es una patología compleja e infrecuente, que requiere un tratamiento multidisciplinario y cuyo pilar es la cirugía.


Objective: Sebaceous carcinoma (SC) is an infrequent neoplasm, without national reports nor management guidelines in Chile. National Cancer Institute (NCI) is a reference center for this kind of disease. The aim of this research is to describe the experience and treatment of the sebaceous carcinoma in our center. Methods: A retrospective, descriptive review of clinical records was performed, between March 2016 and March 2022 at the INC, in which the definitive biopsy was confirmatory of CS. Results: A total of 10 patients were enrolled; 6 male (60%) and 4 women. The mean age was 62.9 years ± 18.7 (SD). 80% of the cases were located at the head or the cervical area and only 2 cases were found in the ocular region (20%). Association with SMT (40%) was found in 4 patients. Surgical treatment with oncological resection and intraoperative assessment of margins was performed in 100% of the cases, using MMS technique. Sentinel lymph node biopsy (BLNC) was performed in 4 patients (40%), of which none had metastasis. No patient presented local recurrence after surgery and there were no cases of mortality due to CS. No patient received radiotherapy, chemotherapy or adjuvant immunotherapy. Just 1 received adjuvant brachytherapy. Conclusion: SC is a complex and infrequent disease, which requires multidisciplinary treatment mainly with surgery.

4.
Cir Esp (Engl Ed) ; 101(12): 816-823, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36706805

ABSTRACT

INTRODUCTION: To report the clinical results of patients with malignant pancreatic lesions who underwent oncological surgery with vascular resection. The type of intervention performed, types of vascular reconstruction, the pathological anatomy results, postoperative morbidity and mortality, and survival at 3 and 5 years were analyzed. METHODS: Retrospective, cross-sectional and comparative analysis. We include 41 patients with malignant pancreatic lesions who underwent surgery with vascular resection due to vascular involvement, from 2013 to 2021. RESULTS: The most performed surgery was pancreaticoduodenectomy (Whipple procedure) using median laparotomy, in 35 out of the 41 patients (85%). One of the cases in the series was performed laparoscopically. Type 1 reconstruction (simple suture) was performed in 11 (27%) patients, type 2 in 4 (10%) cases, type 3 (end-to-end) in 23 (56%) cases, and type 4 reconstruction by autologous graft in 3 (7%) cases. The mean length of the resected venous segment was 21 (11-46) mm, and mean surgical time was 290 (220-360) minutes. 90% (37/41) were pancreatic adenocarcinoma. 83% were considered R0, and there was involvement in the resected vascular section in 41% of the cases. Four patients had Clavien Dindo morbidity >3, and there were no cases of postoperative mortality. Survival at 3 years was 48% and at 5 years 20%. CONCLUSIONS: The aggressive surgical treatment with venous resection in pancreatic malignant lesions to ensure R0 and its vascular reconstruction is a feasible technique, with an acceptable morbid-mortality rate and overall survival.


Subject(s)
Adenocarcinoma , Pancreatic Neoplasms , Humans , Pancreatic Neoplasms/pathology , Retrospective Studies , Adenocarcinoma/pathology , Cross-Sectional Studies , Veins
5.
Cir Cir ; 90(S1): 121-126, 2022.
Article in English | MEDLINE | ID: mdl-35944111

ABSTRACT

INTRODUCTION: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. The standard management for localized GIST is the complete surgical resection. For this procedure, laparoendoscopic cooperative surgery (LECS) has been proposed as a safe and effective alternative. We want to show our experience with LECS technique for the management of GIST and a literature review. MATERIALS AND METHODS: A retrospective, cross-sectional study was carried out, which included patients with a diagnosis of localized GIST treated with LECS technique between January 2011 and December 2018. RESULTS: During the period of the study, 21 patients were managed by LECS technique, with a male-female rate 3:1. Average surgical time was 98.5 min, 100% negative borders in all patients. Intraoperative bleeding was 30.7 cc and all patients had orally tolerance in the first 24 h. None of them required ICU management, no mortality was reported. CONCLUSIONS: The LECS technique has demonstrated to be a viable, safe, and effective technique for the management of gastric GIST's, showing superiority in organ function preservation and in the range of oncological margins. Prospective studies are necessary to obtain knowledge about the outcome of patients managed through LECS technique.


INTRODUCCIÓN: Los tumores del estroma gastrointestinal (GIST) son las neoplasias mesenquimales más comunes del tracto gastrointestinal. El tratamiento estándar para los GIST localizados es la resección quirúrgica completa. Para este procedimiento, el abordaje cooperativo laparo-endocopico (ACLE) se ha propuesto como una alternativa segura y eficaz. Queremos mostrar nuestra experiencia con la técnica ACLE para el manejo de GIST y unzaa revisión de la literatura. MATERIAL Y MÉTODOS: Se realizó un estudio retrospectivo, transversal, que incluyó pacientes con diagnóstico de GIST localizado tratados con la técnica ACLE entre enero de 2011 y diciembre de 2018. RESULTADOS: Durante el periodo de estudio se manejaron 21 pacientes con técnica de ACLE, con una tasa hombre-mujer de 3:1. El tiempo quirúrgico promedio fue de 98.5 min, con 100% de bordes negativos en todos los pacientes. El sangrado intraoperatorio fue de 30.7 cc y todos los pacientes tuvieron tolerancia oral en las primeras 24H. Ninguno de ellos requirió manejo en UCI, no se reportó mortalidad. CONCLUSIONES: La técnica ACLE ha demostrado ser una técnica viable, segura y eficaz para el manejo de los GIST gástricos. Mostrando superioridad en la preservación de la función orgánica y en los magines oncológicos. Son necesarios estudios prospectivos para conocer el resultado de los pacientes manejados mediante la técnica ACLE.


Subject(s)
Gastrointestinal Stromal Tumors , Laparoscopy , Stomach Neoplasms , Cross-Sectional Studies , Female , Gastrointestinal Stromal Tumors/surgery , Humans , Laparoscopy/methods , Male , Prospective Studies , Retrospective Studies , Stomach Neoplasms/surgery , Treatment Outcome
6.
Article in Spanish | LILACS, CUMED | ID: biblio-1408144

ABSTRACT

Introducción: El cáncer es la principal causa de muerte. Cada año se diagnostican millones de mujeres con cáncer de mama que necesitan tratamiento quirúrgico, para lo cual la anestesia total intravenosa parece ser una excelente opción. Objetivo: Describir los resultados de la aplicación de la anestesia total intravenosa en las pacientes a las que se les efectuó cirugía oncológica de mama. Métodos: Se realizó un estudio observacional, descriptivo, longitudinal, prospectivo, en el Servicio de Anestesiología del Hospital General Docente "Abel Santamaría Cuadrado" en el período comprendido entre enero de 2013 y enero de 2015. Se estudió una población accesible de 111 pacientes seleccionados mediante criterios de inclusión y exclusión. Para el análisis estadístico se utilizaron distribuciones de frecuencias, cálculo de medidas de tendencia central y de dispersión. Algunas de las variables fueron tensión arterial, frecuencia cardíaca, saturación de oxígeno, complicaciones, tiempo de recuperación, nivel de sedación, respuesta analgésica. Resultados: Se logró gran estabilidad hemodinámica en más del 95 por ciento de las pacientes. Se detectó superficialidad anestésica en 1,80 por ciento de los casos. El 92,80 por ciento de los casos se recuperaron entre 10 y 20 min. Se presentó sedación adecuada en 106 pacientes. Las principales complicaciones fueron las náuseas y los vómitos en 9,01 por ciento. Existió una adecuada respuesta analgésica en 93,69 por ciento de los casos. Conclusiones: La aplicación de la anestesia total intravenosa para cirugía oncológica de mama arrojó resultados muy satisfactorios como método anestésico(AU)


Introduction: Cancer is the leading cause of death worldwide. Every year millions of women are diagnosed with breast cancer and they need surgical treatment, for which total intravenous anesthesia seems to be an excellent option. Objective: Describe the results of the application of total intravenous anesthesia in patients undergoing oncological breast surgery. Methods: An observational, descriptive, longitudinal, prospective study was conducted in the Anesthesiology Service of "Abel Santamaría Cuadrado" Hospital in the period between January 2013 and January 2015. An accessible population of 111 patients selected using inclusion and exclusion criteria was studied. For the statistical analysis, frequency distributions, calculation of measures of central tendency and dispersion were used. Some of the variables were blood pressure, heart rate, oxygen saturation, complications, recovery time, level of sedation, analgesic response. Results: High hemodynamic stability was achieved in more than 95 percent of the patients. Anesthetic superficiality was detected in 1.80 percent of cases. 92.80 percent of the cases recovered after 10 to 20 minutes. Adequate sedation was present in 106 patients. The main complications were nausea and vomiting in 9.01 percent There was an adequate analgesic response in 93.69 percent of the cases. Conclusions: The application of total intravenous anesthesia for oncological breast surgery yielded very satisfactory results as an anesthetic method(AU)


Subject(s)
Humans , Female , Breast Neoplasms/drug therapy , Breast Neoplasms/surgery , Epidemiology, Descriptive
7.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(1): 25-33, 2022 01.
Article in English | MEDLINE | ID: mdl-35033483

ABSTRACT

INTRODUCTION: Surgical treatment during Covid-19 pandemic is controversial. Currently, most clinical guidelines advise to defer surgical patients during the Covid-19 pandemic, although the supporting data is sparse. We assumed that a Covid-19-free hospital, on the back of strong isolation measures and targeted screening, could reduce complications and enable us to continue treating high-risk patients. METHODS: Prospective study with retrospective analysis of 355 patients who had undergone nondeferrable oncological surgery between March 16th, 2020, and April 14th, 2020, at our institution. The aim of the study was to assess the hospital restructuring and surgical protocols to be able to safely handle non-deferrable surgeries during the first wave of the Covid-19 pandemic. We implemented structural changes and an updated surgical-anesthetic protocol in order to isolate Covid-19 patients from other surgical patients. Comprehensive targeted screening for Covid-19 patients was made. PCR tests were requested for suspected Covid-19 patients. We analyzed mortality and complications related to both surgery and Covid-19 during hospital admission and also 15 and 30 days after surgery. We compared it with a sample of similar patients in the pre-pandemic period. RESULTS: Of the 355 patients enrolled in our study, 21 were removed due to Covid-19 infection, leaving a total of 334 patients in our final analysis. Post-operative complications were found in 37 patients (11.07%). Two patients died after surgery (0.6%). At the end of the study, Covid-19-related adverse outcomes were detected in six patients (1.79%). When comparing the complications of our original sample with the complications that occurred in the pre-covid era, we found no statistically significant differences. CONCLUSIONS: Our results show that the surgical treatment of oncologic patients during the Covid-19 pandemic is safe, as long as the hospital performs surgeries under strict isolation measures and a robust screening method. It is necessary to select Covid-19 free hospitals for this matter in this and future pandemics.


Subject(s)
COVID-19 , Pandemics , Humans , Prospective Studies , Retrospective Studies , SARS-CoV-2 , Spain/epidemiology
8.
Rev. otorrinolaringol. cir. cabeza cuello ; 81(4): 595-604, dic. 2021. tab
Article in Spanish | LILACS | ID: biblio-1389817

ABSTRACT

Resumen La mayoría de los servicios de salud han experimentado un aumento de los costos asociados a la atención de salud lo que ha llevado a adoptar medidas para optimizar la costo-efectividad de los servicios otorgados. Desde esa perspectiva surge la atención de salud basada en el valor. El concepto de "calidad en la atención de salud" se ha definido como el grado en el cual los servicios de salud aumentan la posibilidad de generar ciertos desenlaces en salud a los que se aspira. Los indicadores de calidad de clasifican en indicadores de estructura, de proceso, y de desenlace. Los indicadores de estructura se refieren a las características del sistema de salud o de la institución hospitalaria. Los indicadores de proceso se refieren a los que el proveedor de servicios de salud realiza para el proceso de atención en salud, mientras que los indicadores de desenlace se refieren a los resultados del proceso en el paciente. El objetivo de la presente revisión es proveer un marco conceptual para dar un contexto al concepto de indicadores de calidad en salud y el rol que estos juegan en cirugía oncológica de cabeza y cuello. Se debe aspirar a lograr un mayor cumplimiento de los indicadores de calidad en cirugía oncológica de cabeza y cuello, especialmente en instituciones terciarias de referencia. Aplicar indicadores de calidad en el manejo oncológico en cabeza y cuello permitiría mejorar tanto la percepción y satisfacción del usuario, como también mejorar resultados oncológicos en estos pacientes.


Abstract Most health services have experienced an increase in the costs associated with health care, which has led to the adoption of measures to optimize the cost-effectiveness of the services provided. From this perspective, the concept of value-based health care emerged. The concept of "quality in health care" has been defined as the degree to which health services increase the possibility of generating certain desired health outcomes. Quality indicators are classified into structure, process, and outcome indicators. The structure indicators refer to the characteristics of the health system or the hospital institution. Process indicators refer to those that the health service provider performs for the health care process, while outcome indicators refer to the results of the process in the patient. The objective of this review is to provide a conceptual framework to give a context to the concept of health quality indicators and the role they play in head and neck surgical oncology. The system should aspire to achieve greater compliance with quality indicators in head and neck cancer surgery, especially in referral tertiary institutions. Applying quality indicators in head and neck cancer management would improve both user perception and satisfaction, as well as improve oncological results in these patients.


Subject(s)
Humans , Male , Female , Quality of Health Care/organization & administration , Quality Indicators, Health Care/organization & administration , Head and Neck Neoplasms/surgery , Cost Efficiency Analysis , Cost-Benefit Analysis
9.
Rev. venez. cir. ortop. traumatol ; 53(2): 50-57, dic. 2021. tab, graf
Article in Spanish | LILACS, LIVECS | ID: biblio-1517285

ABSTRACT

Se presenta un análisis de las clasificaciones previamente publicadas para las complicaciones que ocurren después de una cirugía realizada para extirpar un tumor que afecta a los huesos. En cuanto a la importancia de ofrecer una propuesta sencilla, fácil de entender, completa, y orientada a las posibilidades de manejo de esas complicaciones, se presenta una nueva propuesta de clasificación(AU)


An analysis of previously published classifications for complications happening after a surgery performed to remove a tumor affecting bones, is presented, and commented. Regarding the importance of offering a simple, easy to understand, complete, and aimed at the possibilities of management of those complications, a new proposal for classification is presented(AU)


Subject(s)
Humans , Bone Neoplasms/surgery , Orthopedic Procedures , Postoperative Care , Disease Progression , Infections
10.
Article in English, Spanish | MEDLINE | ID: mdl-34565569

ABSTRACT

INTRODUCTION: Surgical treatment during COVID-19 pandemic is controversial. Currently, most clinical guidelines advise to defer surgical patients during the COVID-19 pandemic, although the supporting data is sparse. We assumed that a COVID-19-free hospital, on the back of strong isolation measures and targeted screening, could reduce complications and enable us to continue treating high-risk patients. METHODS: Prospective study with retrospective analysis of 355 patients who had undergone nondeferrable oncological surgery between March 16th, 2020, and April 14th, 2020, at our institution. The aim of the study was to assess the hospital restructuring and surgical protocols to be able to safely handle non-deferrable surgeries during the first wave of the COVID-19 pandemic. We implemented structural changes and an updated surgical-anesthetic protocol in order to isolate COVID-19 patients from other surgical patients. Comprehensive targeted screening for COVID-19 patients was made. PCR tests were requested for suspected COVID-19 patients. We analyzed mortality and complications related to both surgery and COVID-19 during hospital admission and also 15 and 30 days after surgery. We compared it with a sample of similar patients in the pre-pandemic period. RESULTS: Of the 355 patients enrolled in our study, 21 were removed due to COVID-19 infection, leaving a total of 334 patients in our final analysis. Post-operative complications were found in 37 patients (11.07%). Two patients died after surgery (0.6%). At the end of the study, COVID-19-related adverse outcomes were detected in six patients (1.79%). When comparing the complications of our original sample with the complications that occurred in the pre-COVID era, we found no statistically significant differences. CONCLUSIONS: Our results show that the surgical treatment of oncologic patients during the COVID-19 pandemic is safe, as long as the hospital performs surgeries under strict isolation measures and a robust screening method. It is necessary to select COVID-19 free hospitals for this matter in this and future pandemics.

11.
Cir Esp (Engl Ed) ; 99(3): 174-182, 2021 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-33341242

ABSTRACT

The SARS-CoV-2 (COVID-19) pandemic requires an analysis in the field of oncological surgery, both on the risk of infection, with very relevant clinical consequences, and on the need to generate plans to minimize the impact on possible restrictions on health resources. The AEC is making a proposal for the management of patients with hepatopancreatobiliary (HPB) malignancies in the different pandemic scenarios in order to offer the maximum benefit to patients, minimising the risks of COVID-19 infection, and optimising the healthcare resources available at any time. This requires the coordination of the different treatment options between the departments involved in the management of these patients: medical oncology, radiotherapy oncology, surgery, anaesthesia, radiology, endoscopy department and intensive care. The goal is offer effective treatments, adapted to the available resources, without compromising patients and healthcare professionals safety.


Subject(s)
COVID-19/prevention & control , Digestive System Neoplasms/surgery , Infection Control/organization & administration , Patient Selection , Surgical Oncology/organization & administration , COVID-19/epidemiology , COVID-19/transmission , Digestive System Neoplasms/pathology , Humans
12.
Rev Esp Anestesiol Reanim (Engl Ed) ; 67(1): 15-19, 2020 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-31353039

ABSTRACT

INTRODUCTION: Cytoreductive surgery with hyperthermic intraoperative chemotherapy (HITHOC) is a therapeutic option for treatment of malignant pleural mesothelioma. Anesthetic management might be challenging. PATIENTS AND METHODS: A descriptive analysis of a case series is presented. Seven patients with malignant pleural mesothelioma diagnostic undergoing HITHOC surgery were studied. Combined general and epidural anesthesia were administered. An intensive hemodynamic monitorization was implemented. Data regarding perioperative course was analyzed. RESULTS: Between May 2015 and October 2018 7patients underwent HITHOC procedure. Blood transfusions were administered in all patients, and 5of the 7patients required vasoactive drug administration. Extubation at the end of the procedure was able in 6of the 7patients. The median length of stay in ICU was 4 days, and 29 days for the whole hospitalary stay. No significant postoperative pain was observed. CONCLUSIONS: HITHOC surgery is a complex procedure in which several hemodynamic changes occur. An intensive intraoperative monitorization was useful for controlling complications.


Subject(s)
Anesthesia, Epidural/methods , Anesthesia, General/methods , Hyperthermia, Induced/methods , Mesothelioma, Malignant/surgery , Pleural Neoplasms/surgery , Aged , Antineoplastic Agents/administration & dosage , Cisplatin/administration & dosage , Combined Modality Therapy/methods , Female , Humans , Length of Stay , Male , Mesothelioma, Malignant/drug therapy , Middle Aged , Pemetrexed/administration & dosage , Pleural Neoplasms/drug therapy
13.
Rev. cir. (Impr.) ; 71(5): 392-397, oct. 2019. tab
Article in Spanish | LILACS | ID: biblio-1058292

ABSTRACT

Resumen Introducción: El cáncer colorrectal es la cuarta patología neoplásica en incidencia y mortalidad en Colombia y, aunque hay evidente mejoría en sus desenlaces, este alto volumen hace indispensable la participación integrada de cirujanos colorrectales y cirujanos generales dedicados a esa área de interés. A la fecha es la cirugía el pilar del tratamiento de esta enfermedad, la cual debe ser realizada dentro de unos parámetros que permitan asegurarle al paciente la resección completa de la misma. Uno de estos parámetros incluye un adecuado vaciamiento ganglionar que nos permite evaluar el pronóstico de la enfermedad y la necesidad de terapias complementarias. Objetivo: Evaluar la calidad de la disección ganglionar en la cirugía oncológica colorrectal efectuada por cirujanos generales en dos instituciones de la ciudad de Bogotá. Materiales y Método: Estudio observacional analítico de corte transversal; se analizaron 315 pacientes llevados a cirugía electiva oncológica colorrectal por cirujanos generales en el periodo de 2014 a 2017 en nuestras instituciones. Resultados: La mediana de ganglios linfáticos recuperados fue de 16, el número de ganglios disecados se asoció con localización del tumor (p = 0,002) y la neoadyuvancia (p = 00,001). Sin embargo, no se encontró asociación con el sexo, tipo de abordaje y volumen de sangrado. Conclusiones: Las colectomías realizadas por cirujanos generales mantienen un volumen óptimo en relación a la disección ganglionar sin comprometer el resto de los desenlaces. El número de ganglios linfáticos recuperados se asoció con la localización del tumor y la terapia neoadyuvante.


Introduction: Colorectal cancer is the 4th neoplastic disease in terms of incidence and mortality in Colombia, even though the clinical outcomes are improving. The high volume of this patients is requesting the collaboration between colorectal surgeons and general surgeons dedicated to this area of interest. To date is surgery the mainstay of the treatment of this disease which should be carried out within parameters that allow to assure the patient the complete resection of the lesion. One of these parameters includes a suitable lymph node emptying that allows us to evaluate the prognosis of the disease and the need of complementary therapies. Aim: To evaluate the quality of the lymph node dissection in colorectal surgery performed by general surgeons in two academic institutions in Bogota, Colombia. Materials and Method: Transversal cohort in analytical and observational study. We analyzed 315 patients scheduled for elective colorectal surgery by general surgeons in the period from 2014 to 2017 in our institutions. Results: The mean of the lymph node recovered was 16, the number of dissected lymph nodes was associated with the tumor location (p = 0.002), and the neoadjuvant (p = 0.001). However, no association within sex, approach and bleeding was found. Conclusions: The colectomies performed by general surgeons maintain an optimal volume in relation with lymph node dissection without affect the remaining clinical outcomes. The number of lymph nodes recovered is associated with tumor location and neoadjuvant therapy.


Subject(s)
Humans , Colectomy/methods , Surgeons , Oncologists , Lymph Node Excision/methods , Colorectal Neoplasms/surgery , Colombia , Surgical Oncology/methods
14.
Rev. cuba. cir ; 58(3): e804, jul.-set. 2019. tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1098971

ABSTRACT

RESUMEN Introducción: La magnitud de las resecciones de tumores de cabeza y cuello, depende del tamaño tumoral, la adecuación de los márgenes y factores inherentes al paciente. El músculo temporal, constituye una excelente opción para reconstruir defectos de zonas aledañas a su sitio de implantación. Objetivo: Demostrar la versatilidad del colgajo miofascial de temporal para la reconstrucción tras, cirugía oncológica de cabeza y cuello, en el Hospital Provincial Universitario "Camilo Cienfuegos Gorriarán" desde enero de 2017 a diciembre de 2018. Métodos: Se realizó una revisión retrospectiva de los informes operatorios de los casos intervenidos con cirugía oncológica de cabeza y cuello, en el servicio de cirugía maxilofacial; se tomó de muestra a pacientes a los que, se les realizó reconstrucción del defecto quirúrgico, utilizándose colgajo miofascial de temporal. Resultados: Fueron sometidos a reconstrucción, 12 pacientes de forma inmediata, en un solo tiempo quirúrgico. El defecto se presentó mayormente en lesiones de piel. La edad promedio de los pacientes fue 66,2 años. Se observó una distribución equitativa en cuanto a sexo, con 6 pacientes para cada grupo. El seguimiento osciló entre 2 y 20 meses, con una media de 11,25 meses, de los cuales todos los pacientes se encontraban vivos y controlados. Conclusiones: El colgajo temporal continúa siendo una opción válida para la reconstrucción en cirugía oncológica de cabeza y cuello. En la serie revisada no ocurrió necrosis, lo que, lo hace un colgajo muy seguro, con buenos resultados estéticos y funcionales y con buena tolerancia ante los tratamientos oncoespecíficos adyuvantes(AU)


ABSTRACT Introduction: The magnitude of the resections of head and neck tumors depends on the tumor size, the adequacy of the margins and factors inherent to the patient. The temporal muscle is an excellent option for reconstructing defects in areas surrounding its implantation site. Objective: To demonstrate the versatility of the temporal myofascial flap for reconstruction after oncological head and neck surgery, at the "Camilo Cienfuegos Gorriarán" Provincial University Hospital from January 2017 to December 2018. Methods: A retrospective review of the operative reports of the cases intervened with oncological head and neck surgery was performed in the maxillofacial surgery service; A sample was taken from patients who underwent reconstruction of the surgical defect, using a temporal myofascial flap. Results: 12 patients underwent reconstruction immediately, in a single surgical time. The defect occurred mainly in skin lesions. The average age of the patients was 66.2 years. An equitable distribution in terms of sex was observed, with 6 patients for each group. Follow-up ranged from 2 to 20 months, with a mean of 11.25 months, of which all the patients were alive and controlled. Conclusions: The temporary flap continues to be a valid option for reconstruction in head and neck cancer surgery. Necrosis did not occur in the revised series, which makes it a very safe flap, with good aesthetic and functional results and with good tolerance to adjuvant oncospecific treatments(AU)


Subject(s)
Humans , Male , Female , Aged , Surgical Flaps/adverse effects , Facial Neoplasms/surgery , Plastic Surgery Procedures/methods , Retrospective Studies
15.
Rev. cuba. anestesiol. reanim ; 18(2): e494, mayo.-ago. 2019. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1093104

ABSTRACT

Introducción: La anestesia total intravenosa se caracteriza por estabilidad hemodinámica, profundidad anestésica, recuperación rápida y predecible, menor cantidad de medicamentos y menor toxicidad. Objetivo: Describir los resultados de la anestesia total intravenosa en cirugía oncológica de mama. Método: Se realizó un estudio descriptivo, longitudinal en el Hospital Clínico Quirúrgico Hermanos Ameijeiras, entre enero de 2016 a diciembre 2016, en 100 pacientes a las que se les administró anestesia total intravenosa con midazolam y fentanilo para proceder quirúrgico oncológico de mama. En ellas se determinó la repercusión hemodinámica, el nivel de sedación, analgesia, la recuperación y complicaciones. Resultados: La media de la edad de las pacientes fue 58,99 ± 12,5 años. De las pacientes en estudio 92 por ciento no presentó signos clínicos de superficialidad. Solo 21 pacientes presentaron complicaciones. Las variaciones de la tensión arterial fueron las más frecuentes (16 por ciento), seguidas de la bradicardia o taquicardia en solo cuatro casos. De forma inmediata se recuperó 74 por ciento de los casos y 26 por ciento restante lo hizo de manera mediata. El nivel de sedación fue adecuado en 50 por ciento y excesivo en 4 por ciento. Del total de los casos, 99 por ciento experimentaron respuesta analgésica sin dolor. Conclusiones: Los resultados del uso de anestesia total intravenosa fueron buenos, con adecuada respuesta analgésica y escasas complicaciones(AU)


Introduction: Total intravenous anesthesia is characterized by hemodynamic stability, anesthetic depth, rapid and predictable recovery, less medication and less toxicity. Objective: To describe the outcomes of total intravenous anesthesia in breast cancer surgery. Method: A descriptive, longitudinal study was carried out in Hermanos Ameijeiras Clinical-Surgical Hospital, from January 2016 to December 2016, in 100 patients who were administered total intravenous anesthesia with midazolam and fentanyl for breast oncology surgery. The patients were determined hemodynamic repercussion, the level of sedation, analgesia, recovery and complications. Results: The mean age of the patients was 58.99±12.5 years. Among the patients under study, 92 percent did not present clinical signs of superficiality. Only 21 patients presented complications. Variations in blood pressure were the most frequent (16 percent), followed by bradycardia or tachycardia in only four cases. Immediately, 74 percent of the cases were recovered and the remaining 26 percent did so timely. The level of sedation was adequate in 50 percent and excessive in 4 percent. Among the total number of cases, 99 percent experienced analgesic response without pain. Conclusions: The outcomes of total intravenous anesthesia usage were good, with adequate analgesic response and few complications(AU)


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Breast Neoplasms/surgery , Anesthesia, Intravenous/methods , Epidemiology, Descriptive , Prospective Studies , Longitudinal Studies
16.
Cir Esp (Engl Ed) ; 97(4): 203-212, 2019 Apr.
Article in English, Spanish | MEDLINE | ID: mdl-30777256

ABSTRACT

INTRODUCTION: Soft tissue sarcomas (SFT) are a group of rare and heterogeneous neoplasms (representing less than 1% of cancer in adults and 15% in pediatric patients), for which there is no updated records in the Latin American population. This study aims to describe the current situation of patients treated at a cancer institute in Latin America. METHODS: We obtained records from 250 patients with a diagnosis of SFT, treated at the National Institute of Neoplastic Diseases of Peru (INEN) during the period 2009-2013, with a mean follow-up of 62 months. The following data were recorded: epidemiological, clinical, treatment and follow-up. The analysis of global survival was done with the Cox proportional hazards model. RESULTS: SFT showed a greater frequency in males (60.8%), with a peak incidence after 50 years of age (69.6%). Tumor location was predominantly in the lower extremities (64.4%), and the most frequent histologic subtypes were: undifferentiated pleomorphic sarcoma (34%) and liposarcomas (25.6%); clinical stage iii was the most frequent (30.8%). The 5-year overall survival rate was 63.9%, while the statistical analysis found a significant association between global survival and the variables: age (>50 years), tumor size (>5cm), depth (subfascial), histologic grade (G3), local and distant recurrence, showing shorter survival times in these groups. CONCLUSIONS: This study has clarified the epidemiology, treatment and prognosis, as well as the variables that have an impact on the survival of the Latin American patients with SFT studied.


Subject(s)
Sarcoma/epidemiology , Sarcoma/mortality , Soft Tissue Neoplasms/epidemiology , Soft Tissue Neoplasms/mortality , Adolescent , Adult , Aged , Aged, 80 and over , Child , Disease-Free Survival , Female , Follow-Up Studies , Humans , Latin America/epidemiology , Liposarcoma/pathology , Lower Extremity/pathology , Male , Middle Aged , Peru/epidemiology , Prognosis , Registries , Retrospective Studies , Sarcoma/pathology , Sarcoma/surgery , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/surgery , Young Adult
17.
Cir Esp ; 95(6): 328-334, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-28645422

ABSTRACT

INTRODUCTION: Venous thromboembolism (VTE) represents a serious complication after oncologic surgery. Recent studies have shown that the risk of VTE persists several weeks after surgery. This study assesses the form of presentation and time course of VTE after abdominal and pelvic cancer surgery. METHODS: Prospective, multicenter, observational study that analyzes data from an international registry (RIETE) that includes consecutive patients with symptomatic VTE. Our study assesses the form and time of presentation of postoperative VTE, as well as main outcomes, in patients operated for abdominopelvic cancer 8 weeks prior to VTE diagnosis. Variables related to the presentation of VTE after hospital discharge are identified. RESULTS: Out of the 766 analyzed patients with VTE, 395 (52%) presented pulmonary embolism (PE). Most VTE cases (84%) were detected after the first postoperative week, and 38% after one month. Among patients with VTE in the first postoperative week, 70% presented PE. VTE presented after hospital discharge in 54% of cases. Colorectal, urologic, and gynecologic tumors, the use of radiotherapy, and blood hemoglobin levels were independently associated with VTE diagnosis after hospital discharge. Complications (thrombosis recurrence, bleeding, and death) occurred in 34% of patients with VTE detected before hospital discharge, compared to 24% in VTE after hospital discharge (P<0.01). CONCLUSIONS: VTE occurs after hospital discharge in most patients, particularly in those operated for colorectal, urologic, and gynecologic cancer. Pulmonary embolism is more frequent in patients who develop early VTE, who also have worse prognosis.


Subject(s)
Postoperative Complications/diagnosis , Venous Thromboembolism/diagnosis , Abdominal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Humans , Internationality , Middle Aged , Pelvic Neoplasms/surgery , Prospective Studies , Registries , Young Adult
18.
Rev. chil. cir ; 68(2): 180-185, abr. 2016. ilus
Article in Spanish | LILACS | ID: lil-784851

ABSTRACT

Malignant tumors of tongue are a common pathology with high morbidity and mortality. Treatment requires surgical oncology and systemic management, with the respective reconstruction in order to achieve an adequate quality of life, due to the primary function of the tongue during feeding, communication, social and labor interaction. That is why the choice of donor tissue for reconstruction depends heavily on its characteris-tics and the type of defect, essential to obtain favorable results in the patients. A review of the classification of resulting defects after tongue's tumors resection is performed, and management algorithm and microvascular free flaps more frequently used in this type of reconstruction.


Los tumores malignos de lengua son una patología frecuente con alto grado de morbilidad y mortalidad. Su tratamiento requiere manejo quirúrgico y sistémico oncológico, con la respectiva reconstrucción, para lograr así una adecuada calidad de vida, debido a la función primordial de la lengua durante la alimentación, la comunicación, la interacción social y laboral. Es por esto que la elección de los tejidos donantes para ello depende en gran medida de sus características y del tipo de defecto, aspecto fundamental para obtener resultados favorables en los pacientes. Se realiza una revisión de la clasificación de los defectos resultantes después de la resección de tumores de lengua, un algoritmo de manejo y los colgajos libres microvasculares más utilizados en este tipo de reconstrucción.


Subject(s)
Humans , Surgical Flaps , Tongue Neoplasms/surgery , Plastic Surgery Procedures/methods
19.
Rev Esp Anestesiol Reanim ; 62 Suppl 1: 45-51, 2015 Jun.
Article in Spanish | MEDLINE | ID: mdl-26320344

ABSTRACT

Preoperative anemia in patients with cancer is highly prevalent, is associated with increased perioperative morbidity and is a risk factor for transfusion. There is evidence that patients who undergo transfusions have higher morbidity, increased cancer recurrence and poorer survival. The pathophysiology of anemia is multifactorial, with an inflammatory component to which chronic blood loss and nutritional deficiencies can be associated. Therefore, preoperative anemia in patients with cancer should be treated appropriately, given that there is sufficient time in the preoperative period. Of the currently available options, parenteral iron is an effective alternative, especially for those types of cancer that have an associated hemorrhagic component.


Subject(s)
Anemia/therapy , Hemoglobins/analysis , Neoplasms/surgery , Preoperative Care/methods , Anemia/diagnosis , Anemia/etiology , Anemia/physiopathology , Biomarkers , Blood Loss, Surgical , C-Reactive Protein/analysis , Erythropoietin/therapeutic use , Ferritins/blood , Forecasting , Hematinics/therapeutic use , Humans , Iron/administration & dosage , Iron/therapeutic use , Medical Errors/prevention & control , Neoplasms/blood , Neoplasms/complications , Recombinant Proteins/therapeutic use , Transfusion Reaction
20.
Rev. cuba. anestesiol. reanim ; 12(2): 139-150, abr.-jun. 2013.
Article in Spanish | LILACS | ID: lil-739135

ABSTRACT

Introducción: la vía aérea del paciente oncológico se comporta como una vía respiratoria difícil conocida donde la incidencia se incrementa, así como la morbimortalidad, dado por las condiciones propias del paciente, de su enfermedad de base y de los tratamientos adyuvantes. Objetivo: identificar la incidencia de vía aérea difícil del paciente oncológico cuyo proceder quirúrgico se encuentra en la cabeza y el cuello. Métodos: se realizó un estudio descriptivo, prospectivo en el Hospital Docente de Oncología «María Curie¼ en el período de enero de 2010 a diciembre de 2010. La muestra incluyó 210 pacientes estudiados con el propósito de identificar la morbimortalidad de la vía aérea difícil en Cirugía Oncológica de cabeza y cuello en nuestra Institución. Resultados: la gran mayoría de pacientes se encontraba entre ASA II y ASA III. La obesidad, tumoraciones de vía aérea y antecedentes de radioterapia influyeron en al aparición de vía aérea difícil. Poca incidencia de ventilación difícil (3,3 %) e intubación fallida (0,4 %), con relación a la laringoscopia difícil (26,2 %), e intubación difícil (30,9 %). Existió coexistencia de ambas entre ellas. La estrategia más usada fue la intubación con el paciente dormido, conservación de la ventilación espontánea y técnicas no invasivas. La máscara laríngea clásica, la máscara laríngea para intubar o Fastrach, y la guía de Eschmann fueron los métodos alternativos más usados. No se presentaron complicaciones. Conclusiones: el adecuado pronóstico y estrategia de abordaje de la vía aérea difícil eleva los niveles de supervivencia de los pacientes tratados por procedimientos quirúrgicos oncológicos de cabeza y cuello.


Background: the airways in an oncology patient behaves like a known difficult airway in which the incidence increases as well as morbimortality because of the own conditions of the patient, his basic disease and adjuvant treatments. Objective: to identify the incidence of difficult airway in the oncology patient that undergoes surgical procedure of in the head and neck. Methods: a descriptive prospective study was conducted in "María Curie" Oncology Teaching Provincial Hospital during the period from January 2010 to December 2010. The sample included 210 patients studied with the purpose of identifying morbimortality of the difficult airway in Oncology Surgery of the head and neck in our institution. Results: the great majority of patients were between ASA II and ASA III. Obesity, tumors of the airway, and a history of radiotherapy influenced the appearance of a difficult airway. There was a low incidence of difficult ventilation (3, 3 %), failed intubations (0, 4 %), in relation to difficult laryngoscopy (26, 2 %) and difficult intubations (30.9 %). Coexistence of both existed between them. The most used strategy was asleep intubation, maintenance of spontaneous ventilation and non-invasive techniques. The classic laryngeal mask, the laryngeal mask for intubations or Fastrach, and Eschmann guide were the most commonly used alternative methods. There were no complications. Conclusions: the adequate prognosis and strategy for approaching the difficult airway increases survival rates in patients treated by oncologic surgical procedures of the head and neck.

SELECTION OF CITATIONS
SEARCH DETAIL